News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Alyson Moadel-Robblee, PhD

Advertisement

Articles by Alyson Moadel-Robblee, PhD

Alyson Moadel-Robblee on Barriers to Counseling for Patients with Prostate Cancer

ByAlyson Moadel-Robblee, PhD
March 11th 2017

Alyson Moadel-Robblee, PhD, discusses what keeps male patients with prostate cancer from seeking out counseling and therapy.

Advertisement

Latest Updated Articles

  • Alyson Moadel-Robblee on Barriers to Counseling for Patients with Prostate Cancer
    Alyson Moadel-Robblee on Barriers to Counseling for Patients with Prostate Cancer

    Published: March 11th 2017 | Updated:



Advertisement
Advertisement

Trending on Oncology Nursing News

1

T-DXd/Pertuzumab Combo Earns FDA Approval in Advanced HER2+ Breast Cancer

2

FDA Greenlights Niraparib/Abiraterone Acetate With Prednisone in mHSPC

3

Pembrolizumab Plus RT Ups T-Cell Infiltration in Early Breast Cancer

4

Teclistamab/Daratumumab Increases OS, PFS in R/R Multiple Myeloma

5

Oral Azacitidine Yields Similar PK to Subcutaneous Azacitidine in MDS/CMML

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us